ViewRay has received FDA 510(k) premarket notification clearance for its MRI-guided radiation therapy system.

Philips Healthcare has made wireless portable detector-sharing functionality available on its static and mobile DR and DR/fluoroscopy equipment, allowing hospitals to use one detector on multiple DR modalities.

With our June 1 newsletter, healthimaging.com debuts its Best Of newsletter. Each week our editorial team will review the weeks stories and compile the top five or six for our readers to revisit.

The Million Hearts initiative gained another ally in its effort to prevent a million heart attacks and strokes in five years with the inclusion of the American College of Physicians (ACP).

Radiation dose associated with imaging is always a hot topic in healthcare. We know the possible risks associated with radiation dose emitted through medical modalities, yet we have to trust that exposure may lead to a diagnosis or perhaps a cure. However, what happens when those risks outweigh the potential benefits?

Boehringer Ingelheim and Eli Lilly have received a positive opinion from the European Medicines Agency's medicinal committee recommending approval of Jentadueto (linagliptin/metformin hydrochloride) tablets, a medicine combining the DPP-4 inhibitor linagliptin and metformin in a single tablet taken twice daily.

The editorial team at Cardiovascular Business is requesting that you participate in a brief survey, so we can learn more about your professional interests and needs. All respondents will be entered into a random drawing for a VISA gift card on June 22.

The editorial team at Health Imaging is requesting your input in a brief survey, so we can learn more about the professional interests and needs of you, our readers. All respondents will be entered into a random drawing for a VISA gift card on June 22.